HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Langleben Selected Research

riociguat

12/2022Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
1/2022Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension.
10/2021Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
2/2021Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry.
1/2021Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
1/2021Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
1/2021Riociguat: Clinical research and evolving role in therapy.
10/2020Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE.
10/2020Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study.
7/2020Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Langleben Research Topics

Disease

40Pulmonary Arterial Hypertension
12/2022 - 12/2003
17Pulmonary Hypertension
01/2023 - 06/2003
9Familial Primary Pulmonary Hypertension
11/2020 - 05/2002
8Connective Tissue Diseases (Connective Tissue Disease)
01/2021 - 02/2004
3Hemorrhage
02/2021 - 11/2012
3Hypotension (Low Blood Pressure)
01/2021 - 01/2017
3Congenital Heart Defects (Congenital Heart Defect)
05/2006 - 02/2004
2Venous Thromboembolism
01/2023 - 11/2012
2Hemoptysis
02/2021 - 01/2021
2Lung Diseases (Lung Disease)
01/2021 - 01/2020
2Heart Diseases (Heart Disease)
01/2021 - 01/2020
2Systemic Scleroderma (Systemic Sclerosis)
10/2014 - 12/2013
2Atrial Fibrillation
03/2014 - 06/2012
2Dyspnea (Shortness of Breath)
07/2013 - 05/2006
1Diabetes Mellitus
02/2022
1Obesity
02/2022
1Raynaud Disease (Raynaud's Disease)
01/2021
1Cough
01/2021
1Cystic Fibrosis (Mucoviscidosis)
01/2021
1Dyspepsia (Indigestion)
01/2021
1Headache (Headaches)
01/2021
1Ischemia
01/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2021
1Disease Progression
01/2021
1Diffuse Scleroderma (Progressive Systemic Sclerosis)
01/2021
1Vascular Diseases (Vascular Disease)
07/2017
1Pulmonary Embolism
07/2017
1Angina Pectoris
04/2017
1Right Ventricular Dysfunction
03/2014
1Mixed Connective Tissue Disease (MCTD)
12/2013
1Ventricular Remodeling
09/2013
1Myocardial Infarction
09/2013
1Necrosis
09/2013
1Coronary Artery Disease (Coronary Atherosclerosis)
09/2013
1Heart Failure
09/2013
1Atherosclerotic Plaque (Atheroma)
09/2013
1Infarction (Infarctions)
09/2013
1Inflammation (Inflammations)
09/2013
1Stroke (Strokes)
06/2012
1Ischemic Stroke
06/2012
1Intracranial Hemorrhages (Intracranial Hemorrhage)
06/2012

Drug/Important Bio-Agent (IBA)

18riociguatIBA
12/2022 - 07/2013
8Endothelin-1 (Endothelin 1)IBA
12/2015 - 12/2005
6Soluble Guanylyl CyclaseIBA
02/2021 - 07/2013
6Endothelin Receptor AntagonistsIBA
07/2020 - 03/2007
6sitaxsentanIBA
12/2015 - 02/2004
5Vasodilator Agents (Vasodilators)IBA
08/2022 - 02/2004
5Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2021 - 02/2014
5Endothelins (Endothelin)IBA
09/2013 - 06/2003
4AnticoagulantsIBA
01/2023 - 06/2012
4Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2021 - 01/2017
3ProstaglandinsIBA
07/2020 - 07/2013
3Endothelin A ReceptorIBA
11/2007 - 10/2004
2Vitamin KFDA Link
01/2022 - 11/2012
2selexipagIBA
01/2021 - 01/2020
2Phosphodiesterase 5 InhibitorsIBA
10/2020 - 01/2020
2pro-brain natriuretic peptide (1-76)IBA
01/2016 - 07/2013
2Carbon MonoxideIBA
10/2014 - 12/2013
2Biomarkers (Surrogate Marker)IBA
10/2014 - 12/2013
2Endothelin Receptors (Endothelin Receptor)IBA
09/2013 - 11/2007
2SodiumIBA
11/2004 - 10/2004
2Vasoconstrictor AgentsIBA
02/2004 - 05/2002
1Estrogens (Estrogen)FDA Link
02/2022
1Hormones (Hormone)IBA
02/2022
1N(4)-oleylcytosine arabinosideIBA
01/2022
1Epoprostenol ReceptorsIBA
01/2021
1Bone Morphogenetic Protein ReceptorsIBA
11/2020
1treprostinilFDA Link
01/2020
1LigandsIBA
07/2017
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
07/2017
1glycyl- glycyl- alanyl- glycyl- cysteinyl- (PEG)4- cysteinyl- adrenomedullin (22-52)IBA
07/2017
1Adrenomedullin ReceptorsIBA
07/2017
1Tadalafil (Cialis)FDA Link
04/2017
1Guanosine Monophosphate (5' Guanylic Acid)IBA
01/2017
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
09/2015
1Nitric Oxide Synthase (NO Synthase)IBA
09/2015
1Antidepressive Agents (Antidepressants)IBA
12/2014
1Serotonin (5 Hydroxytryptamine)IBA
12/2014
1Glycine (Aminoacetic Acid)FDA LinkGeneric
02/2014
1Excipients (Suspending Agents)IBA
02/2014
1Arginine (L-Arginine)FDA Link
02/2014
1Sucrose (Saccharose)IBA
02/2014
1Mannitol (Osmitrol)FDA LinkGeneric
02/2014
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
12/2013
1Brain Natriuretic Peptide (Natrecor)FDA Link
07/2013
1apixabanIBA
11/2012
1RivaroxabanIBA
11/2012
1ximelagatran (Exanta)IBA
11/2012
1DabigatranFDA Link
11/2012
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
06/2012
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2012
1Warfarin (Coumadin)FDA LinkGeneric
06/2012
1Transforming Growth Factor beta (TGF-beta)IBA
12/2010
1Peptides (Polypeptides)IBA
12/2010
1Proteins (Proteins, Gene)FDA Link
12/2010
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2008

Therapy/Procedure

20Therapeutics
01/2023 - 02/2004
1Endarterectomy (Thromboendarterectomy)
01/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
09/2015
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
03/2014